These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24815325)

  • 1. Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.
    Patel K; Remlinger KS; Walker TG; Leitner P; Lucas JE; Gardner SD; McHutchison JG; Irving W; Guha IN
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2113-20.e1-3. PubMed ID: 24815325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
    Jazwinski AB; Thompson AJ; Clark PJ; Naggie S; Tillmann HL; Patel K
    J Viral Hepat; 2012 Apr; 19(4):278-82. PubMed ID: 22404726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.
    Patel K; Benhamou Y; Yoshida EM; Kaita KD; Zeuzem S; Torbenson M; Pulkstenis E; Subramanian GM; McHutchison JG
    J Viral Hepat; 2009 Mar; 16(3):178-86. PubMed ID: 19175870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients.
    Mansy SS; Nosseir MM; Zoheiry MA; Hassanein MH; Guda MF; Othman MM; AbuTalab H
    Clin Chem Lab Med; 2014 Sep; 52(9):1319-28. PubMed ID: 24803609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.
    El-Kamary SS; Mohamed MM; El-Raziky M; Shardell MD; Shaker OG; ElAkel WA; Esmat G
    Liver Int; 2013 Aug; 33(7):982-90. PubMed ID: 23509874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
    Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
    Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.
    Saleh SA; Salama MM; Alhusseini MM; Mohamed GA
    World J Gastroenterol; 2020 Jun; 26(21):2864-2876. PubMed ID: 32550761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.
    Naveau S; Raynard B; Ratziu V; Abella A; Imbert-Bismut F; Messous D; Beuzen F; Capron F; Thabut D; Munteanu M; Chaput JC; Poynard T
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):167-74. PubMed ID: 15704051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
    Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
    J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
    World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
    Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Hsieh MH; Dai CY; Hsieh MY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Aug; 33(8):394-399. PubMed ID: 28811008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis.
    Poynard T; Lenaour G; Vaillant JC; Capron F; Munteanu M; Eyraud D; Ngo Y; M'Kada H; Ratziu V; Hannoun L; Charlotte F
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):657-63.e7. PubMed ID: 22343514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.
    Usluer G; Erben N; Aykin N; Dagli O; Aydogdu O; Barut S; Cevik F; Ormen B;
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1873-8. PubMed ID: 22231498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.